Old Web
English
Sign In
Acemap
>
authorDetail
>
Christian A. Heidbreder
Christian A. Heidbreder
Chemistry
Antagonist
Buprenorphine
Opioid use disorder
Dopamine receptor D3
4
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes from RECOVER, an Observational Study.
2020
Journal of Addiction Medicine
Walter Ling
Vijay R Nadipelli
Arnie Aldridge
Naoko Ronquest
Caitlyn T. Solem
Howard Chilcoat
Victoria A. Albright
Courtney Johnson
Susan M. Learned
Vishaal Mehra
Christian A. Heidbreder
Show All
Source
Cite
Save
Citations (7)
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
2020
Journal of Clinical Psychopharmacology
Anne Andorn
Barbara R. Haight
Sunita Shinde
Paul J. Fudala
Yue Zhao
Christian A. Heidbreder
Susan M. Learned
Norma Lynn Fox
Vijay R Nadipelli
David R. Hassman
Daniel Rutrick
Show All
Source
Cite
Save
Citations (4)
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.
2009
Bioorganic & Medicinal Chemistry Letters
Fabrizio Micheli
Ian Peter Holmes
Luca Arista
Giorgio Bonanomi
Simone Braggio
Francesca Cardullo
Romano Di Fabio
Daniele Donati
Gabriella Gentile
Dieter Hamprecht
Silvia Terreni
Christian A. Heidbreder
Chiara Savoia
Cristiana Griffante
Angela Worby
Show All
Source
Cite
Save
Citations (9)
The effect of SB-269970-A, a 5-HT7 receptor antagonist, on 5-HT release and cell firing
2001
Claire Roberts
Christopher J. Langmead
Ellen M. Soffin
Ceri H. Davies
L. Lacroix
Christian A. Heidbreder
Show All
Source
Cite
Save
Citations (4)
1